COMBINED oral contraceptives
(COCs) have been shown not to
have an increased risk of venous
thromboembolism (VTE) according
to a new large Australian systematic
review and meta-analysis.
While no increased risk of VTE
with drospirenone was seen in
prospective or case control studies,
the risk of VTE was increased in
retrospective cohort and nested
case control studies.
The difference in risk of VTE based
on the choice of progestin in COCs
is, at worst, very small in absolute
terms, the authors said.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 16
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.